deferiprone has been researched along with Fibroma, Shope in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simonart, T | 1 |
| Boelaert, JR | 1 |
| Mosselmans, R | 1 |
| Andrei, G | 1 |
| Noel, JC | 1 |
| De Clercq, E | 1 |
| Snoeck, R | 1 |
1 other study available for deferiprone and Fibroma, Shope
| Article | Year |
|---|---|
Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells.
Topics: Apoptosis; Cell Division; Deferiprone; Deferoxamine; Female; G1 Phase; Growth Inhibitors; HeLa Cells | 2002 |